Authorized purpose: Concurrent reading aid for adult frontal and lateral chest radiographs, marking suspected nodules, pleural-space abnormalities, mediastinal/hilar abnormalities and consolidations.
Clinical role
Concurrent reading aid that presents annotated output for radiologist or emergency-physician review; final interpretation remains with the clinician.
Images and patients
X-ray/Radiography · Chest/Lung
Key limitation
Keep in mind: The product is an aid and does not replace clinician interpretation. Output labels include NO CHESTVIEW ROI and OUT OF SCOPE when the algorithm cannot provide a relevant result; the cleared scope is adult frontal/lateral chest radiography and listed findings.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Concurrent reading aid for adult frontal and lateral chest radiographs, marking suspected nodules, pleural-space abnormalities, mediastinal/hilar abnormalities and consolidations.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/Lung Input: Adult frontal and lateral chest X-ray examinations received as DICOM; the submission describes the cleared thoracic regions and listed findings.
Who uses it?Intended users: Radiologists, emergency physicians and other qualified healthcare professionals interpreting adult chest radiographs.
What does the software produce?Output: Annotated DICOM output with boxes labeled Nodule, Pleural space abnormality, Mediastinum/Hila abnormality and Consolidation. Solid-line boxes indicate higher specificity and dotted-line boxes indicate higher sensitivity; NO CHESTVIEW ROI and OUT OF SCOPE states are also displayed.
What is its most important limitation?Key limitation: The product is an aid and does not replace clinician interpretation. Output labels include NO CHESTVIEW ROI and OUT OF SCOPE when the algorithm cannot provide a relevant result; the cleared scope is adult frontal/lateral chest radiography and listed findings.
Clinical takeaway. Clinical role: Concurrent reading aid for adult frontal and lateral chest radiographs, marking suspected nodules, pleural-space abnormalities, mediastinal/hilar abnormalities and consolidations.
Evidence takeaway. Evidence from the reviewed source record: The FDA packet defines the annotated outputs and intended thoracic findings but the reviewed summary did not yield a single consolidated performance number suitable for this dossier.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Concurrent reading aid for adult frontal and lateral chest radiographs, marking suspected nodules, pleural-space abnormalities, mediastinal/hilar abnormalities and consolidations.
Annotated DICOM output with boxes labeled Nodule, Pleural space abnormality, Mediastinum/Hila abnormality and Consolidation. Solid-line boxes indicate higher specificity and dotted-line boxes indicate higher sensitivity; NO CHESTVIEW ROI and OUT OF SCOPE states are also displayed.
The product is an aid and does not replace clinician interpretation. Output labels include NO CHESTVIEW ROI and OUT OF SCOPE when the algorithm cannot provide a relevant result; the cleared scope is adult frontal/lateral chest radiography and listed findings.
The FDA packet defines the annotated outputs and intended thoracic findings but the reviewed summary did not yield a single consolidated performance number suitable for this dossier.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The FDA packet defines the annotated outputs and intended thoracic findings but the reviewed summary did not yield a single consolidated performance number suitable for this dossier.
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
ChestView US K241620 validation
DesignRegulatory performance validation described in the FDA 510(k) summary
PopulationAdult frontal and lateral chest radiographs with the listed thoracic findings
Scopeexact submission
Tested versionChestView US configuration submitted in K241620
IndependenceSponsor or vendor study
K241620
The dossier retains the cleared outputs and limitations without inventing a consolidated sensitivity or specificity value.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Adult frontal and lateral chest X-ray examinations received as DICOM; the submission describes the cleared thoracic regions and listed findings.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: DICOM chest radiographs are processed and returned with annotated output for review in the radiology workflow; exact local worklist and PACS routing require site confirmation.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The FDA submission describes a software workflow that receives chest radiographs and returns annotated DICOM images; the public summary does not establish a particular hosting model.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Annotated DICOM output with boxes labeled Nodule, Pleural space abnormality, Mediastinum/Hila abnormality and Consolidation. Solid-line boxes indicate higher specificity and dotted-line boxes indicate higher sensitivity; NO CHESTVIEW ROI and OUT OF SCOPE states are also displayed.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Annotated DICOM output with boxes labeled Nodule, Pleural space abnormality, Mediastinum/Hila abnormality and Consolidation. Solid-line boxes indicate higher specificity and dotted-line boxes indicate higher sensitivity; NO CHESTVIEW ROI and OUT OF SCOPE states are also displayed.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The FDA submission describes a software workflow that receives chest radiographs and returns annotated DICOM images; the public summary does not establish a particular hosting model.
DICOM chest radiographs are processed and returned with annotated output for review in the radiology workflow; exact local worklist and PACS routing require site confirmation.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-07Last searched
24Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
Stored candidate metadata was screened; no PubMed or trial IDs were returned for this submission. This is not a full-paper review. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor label, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-07 - Exact FDA submission
No public price or quote for ChestView US was reviewed.
Pricing model: Not verified - checked 2026-09-07 - Exact FDA submission
License, per-study, subscription and implementation terms were not established.
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Gleamer ChestView reimbursement"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-07 - Exact FDA submission
The reviewed public sources do not establish exact-release security controls, retention or assurance documentation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-10-27 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Second-reader support for radiologists reviewing adult digital AP or PA chest radiographs, with suspected pulmonary nodules in the 6-30 mm range marked for review.
Authorized purpose: Passive study-level worklist triage for suspected pneumothorax and/or pleural effusion on adult PA or AP chest X-rays; it is not a proactive specialist alert.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.